drugset / Trial / NCT00713401
Safety Study of Tecadenoson to Treat Atrial Fibrillation
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Assess the tolerability and safety of a rapid bolus of tecadenoson at different dose levels when given alone and in combination with a beta-blocker (esmolol) in patients with atrial fibrillation to control rapid heart rate. Explore the pharmacokinetic and pharmacodynamic effects when given alone and in combination with beta-blocker (esmolol).
Timeline
- Start
- 2008-02
- Primary completion
- 2008-04
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esmolol | Other / unclassified | 50 ug/kg | — |
| Subject | Tecadenoson | Small molecule | 75 ug | Intravenous |
| Subject | Tecadenoson | Small molecule | 150 ug | Intravenous |
| Subject | Tecadenoson | Small molecule | 300 ug | Intravenous |